title: Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair.
abstract: Abdominal aortic aneurysms (AAAs) are abnormal expansions of the aortic wall, typically characterized by chronic up-regulation of matrix metalloproteases (MMPs)-2 and -9. These MMPs degrade elastin and elastic matrix within the aortic wall, leading to a progressive loss of elasticity of the abdominal aorta as the condition progresses. Doxycycline (DOX) is a tetracycline-based antibiotic which has shown significant promise in delaying and slowing the growth of AAAs in both clinical studies and animal models. However, it has been found to inhibit elastic matrix deposition by vascular cells at dosages in the μg ml(-1) range, which is typically observed in the circulation, in addition to systemic side effects, following oral dosage. In this paper, we describe the development of DOX-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles for localized, controlled and sustained DOX delivery towards AAA therapy. Further, we demonstrate that surface functionalization of these nanoparticles with cationic amphiphiles not only imparts them with a positive charge for potentially enhanced aortic uptake, but also enables enhanced elastin binding via hydrophobic interactions, as well as up-regulating activity of the elastin crosslinking enzyme lysyl oxidase. In addition to the DOX released from the nanoparticles being effective in inhibiting MMP-2 production and activity, we also demonstrate that surface functionalization of the nanoparticles cationic amphiphiles may also play a role in MMP-2 inhibition via (i) electrostatic interactions with negatively charged residues in the active-site of MMP-2 or (ii) steric blockade of the active site on account of the presence of two dodecyl chains in the DMAB molecule. Thus, in addition to enhanced aortic uptake and retention illustrated in studies by other groups, we have demonstrated that cationic functionalization of PLGA nanoparticles enhances elastogenic outcomes by targeted binding to elastin, as well as their potential to inhibit elastolysis. These results establish their multifunctionality as a localized delivery system for AAA therapy. Overall, this delivery system has the potential to enhance regenerative outcomes at sites of proteolytic matrix disruption/degradation by enabling targeted, controlled and long-term release of therapeutic agents.
authors: Department of Biomedical Engineering, The Cleveland Clinic, Cleveland, OH 44195, USA.
authors: Balakrishnan
authors: B
authors: Sivaraman
authors: Anand
authors: A
authors: Ramamurthi
mesh_terms: D000818:Animals; D004318:Doxycycline / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D005109:Extracellular Matrix / Q000187:drug effects* / Q000473:pathology; D019344:Lactic Acid; D008297:Male; D053758:Nanoparticles; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D004318:Doxycycline
references: Expert Opin Drug Deliv. 2008 May;5(5):499-515
references: 18491978
references: Vascular. 2005 Sep-Oct;13(5):290-7
references: 16288704
references: Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1625-33
references: 9763536
references: Anal Biochem. 1980 Mar 1;102(2):344-52
references: 6158890
references: J Cardiovasc Pharmacol. 2003 Oct;42(4):469-76
references: 14508231
references: J Cell Biochem. 2003 Mar 1;88(4):660-72
references: 12577300
references: Expert Rev Mol Diagn. 2009 May;9(4):325-41
references: 19435455
references: Biochemistry. 1974 Aug 13;13(17):3497-503
references: 4846292
references: Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47
references: 12628320
references: Drug Dev Ind Pharm. 2005 Jan;31(1):43-57
references: 15704857
references: Clin Exp Metastasis. 1998 Apr;16(3):217-25
references: 9568639
references: J Mater Sci Mater Med. 2001 Feb;12(2):107-10
references: 15348315
references: Tissue Eng Part A. 2011 Jul;17(13-14):1699-711
references: 21341992
references: Bioconjug Chem. 2004 Jul-Aug;15(4):931-41
references: 15264885
references: Ann Intern Med. 1997 Mar 15;126(6):441-9
references: 9072929
references: J Dent Res. 1985 Jun;64(6):936-9
references: 2987327
references: Acta Biomater. 2010 Jan;6(1):170-8
references: 19505598
references: J Biol Chem. 1981 Jun 10;256(11):5417-21
references: 6113236
references: Mol Pharm. 2004 Jan 12;1(1):77-84
references: 15832503
references: J Control Release. 2003 Sep 19;92(1-2):173-87
references: 14499195
references: Tissue Eng Part A. 2011 Nov;17(21-22):2879-89
references: 21702719
references: Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):429-34
references: 14739119
references: Anal Bioanal Chem. 2007 Jan;387(2):695-701
references: 17102968
references: Adv Dent Res. 1998 Nov;12(2):63-7
references: 9972124
references: Langmuir. 2009 Feb 17;25(4):2369-77
references: 19161268
references: Am J Pathol. 2002 Mar;160(3):1089-95
references: 11891205
references: J Control Release. 2002 Jul 18;82(1):105-14
references: 12106981
references: Expert Rev Cardiovasc Ther. 2009 Aug;7(8):999-1009
references: 19673677
references: Arthritis Rheum. 1996 Feb;39(2):235-44
references: 8849373
references: Ann Vasc Surg. 2006 Mar;20(2):228-36
references: 16572291
references: J Tissue Eng Regen Med. 2011 Feb;5(2):85-96
references: 20653044
references: Circulation. 1996 Sep 15;94(6):1441-8
references: 8823004
references: J Vasc Surg. 2001 Oct;34(4):606-10
references: 11668312
references: J Vasc Surg. 2002 Jul;36(1):1-12
references: 12096249
references: Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):277-90
references: 21392551
references: Arch Pharm Res. 2004 Jan;27(1):1-12
references: 14969330
references: Clin Exp Metastasis. 2000;18(2):139-46
references: 11235989
references: Ann N Y Acad Sci. 2006 Nov;1085:39-46
references: 17182921
references: J Clin Invest. 1991 Dec;88(6):2083-94
references: 1661296
references: J Vasc Surg. 2003 Dec;38(6):1376-83
references: 14681644
references: J Vasc Surg. 1996 Feb;23(2):336-46
references: 8637112
references: FASEB J. 2002 Aug;16(10):1217-26
references: 12153989
references: J Pharm Sci. 1998 Oct;87(10):1229-34
references: 9758682
references: J Clin Invest. 2002 Sep;110(5):625-32
references: 12208863
references: Adv Colloid Interface Sci. 2003 May 30;103(3):219-304
references: 12781966
references: Mol Pharmacol. 2005 Apr;67(4):1128-36
references: 15665254
references: Pharm Res. 2004 Aug;21(8):1428-39
references: 15359578
references: Am J Physiol Lung Cell Mol Physiol. 2010 Sep;299(3):L393-400
references: 20581100
references: Circ Res. 2003 May 2;92(8):827-39
references: 12730128
references: J Vasc Surg. 2000 Feb;31(2):325-42
references: 10664501
references: J Vasc Surg. 2002 May;35(5):923-9
references: 12021708
references: J Antimicrob Chemother. 2008 Feb;61(2):332-40
references: 18174200
references: J Clin Invest. 2000 Jun;105(11):1641-9
references: 10841523
references: Anal Biochem. 2002 Jan 15;300(2):245-51
references: 11779117
references: Bioorg Med Chem Lett. 2009 May 15;19(10):2755-9
references: 19375915
references: Connect Tissue Res. 1981;8(3-4):213-7
references: 6114810
references: J Biomed Mater Res A. 2009 Mar 15;88(4):1022-30
references: 18404709
references: J Biomater Sci Polym Ed. 2006;17(3):247-89
references: 16689015
references: J Vasc Surg. 2004 Jun;39(6):1312-21
references: 15192574
references: J Cell Biol. 1994 Jul;126(2):563-74
references: 8034752
references: Ann Surg. 1979 Feb;189(2):158-64
references: 154875
references: J Vasc Surg. 1998 Dec;28(6):1082-93
references: 9845660
references: Crit Rev Oral Biol Med. 1991;2(3):297-321
references: 1654139
references: Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):483-8
references: 12615694
references: Curr Atheroscler Rep. 2002 May;4(3):222-7
references: 11931720
references: J Dent Res. 2011 Apr;90(4):535-40
references: 21212315
references: Biochem J. 1979 Jan 1;177(1):203-14
references: 34386
references: Ann N Y Acad Sci. 1994 Sep 6;732:140-51
references: 7978787
references: Am J Pathol. 2006 May;168(5):1697-709
references: 16651635
references: Adv Dent Res. 1998 Nov;12(2):114-8
references: 9972133
references: FEBS Lett. 2007 Dec 11;581(29):5723-6
references: 18036564